View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 5, 2022

Cellink and partners to develop diagnostic device to identify infertility

The diagnostic devices will be customised with proteins related to spermatocytes to determine infertility.

Cellink has collaborated with Spermosens, Malmö University and Saint Louis University (SLU) to develop an in-vitro diagnostic (IVD) device to help determine male infertility.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Under the collaboration, the companies will work to develop diagnostic methods and point-of-care devices, including electrochemical systems, printable bioink and optical devices.

The medical devices will be customised with proteins related to spermatocytes, which are the primary cells used to determine the degree of infertility in men.

According to the WHO, infertility is a widespread health condition that is estimated to currently affect more than 48 million couples.

Despite progress being made in the treatment of infertility and ways to conceive, a large gap still exists in diagnosing infertility, with 40% of the cases still going unexplained.

The collaboration partners expect the new diagnostic methods and devices to address the gap in diagnosing infertility, providing improved decision-making and patient results.

Cellink CSO Itedale Namro Redwan said: “Reproductive health is an extremely important field of medicine where the potential of bioprinting has not been realised.

“We are excited to work with such a motivated and knowledgeable group to develop a device that can impact millions of lives.”

The collaboration will use Spermosens’ intellectual property rights to develop new diagnostic methods and point-of-care devices to determine male infertility.

The project is part of Prospekt 21 and will be partly funded by KK Stiftelse.

Spermosens CEO John Lempert said: “We are committed to our mission to develop improved diagnostic solutions to the challenges posed globally by infertility.

“As part of this commitment, we are confident we have found partners that share this goal and will provide a wealth of expertise that will truly accelerate the development process and ultimately benefit to an increased quality of life for the millions affected worldwide.”

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network